Free Trial

Arteris (NASDAQ:AIP) Issues Quarterly Earnings Results

Arteris logo with Computer and Technology background

Key Points

  • Arteris reported a quarterly loss of ($0.21) EPS, underperforming the consensus estimate of ($0.11).
  • The company's shares rose by $3.55 during trading, reaching $13.00, with a trading volume significantly exceeding its average.
  • Rosenblatt Securities maintained a "buy" rating and set a price target of $14.00 for Arteris stock.
  • Five stocks to consider instead of Arteris.

Arteris (NASDAQ:AIP - Get Free Report) issued its quarterly earnings results on Tuesday. The company reported ($0.21) EPS for the quarter, missing the consensus estimate of ($0.11) by ($0.10), Zacks reports. Arteris had a negative net margin of 52.78% and a negative return on equity of 8,546.17%. Arteris updated its FY 2025 guidance to EPS and its Q3 2025 guidance to EPS.

Arteris Price Performance

Shares of Arteris stock traded up $3.55 during trading hours on Tuesday, hitting $13.00. The company had a trading volume of 21,769,928 shares, compared to its average volume of 492,189. The company's 50-day moving average is $8.93 and its two-hundred day moving average is $8.36. Arteris has a twelve month low of $5.46 and a twelve month high of $14.29. The company has a market cap of $545.74 million, a P/E ratio of -15.85 and a beta of 1.45.

Wall Street Analyst Weigh In

Separately, Rosenblatt Securities reiterated a "buy" rating and set a $14.00 price target on shares of Arteris in a report on Wednesday, May 21st.

Get Our Latest Report on Arteris

Insider Activity

In other news, Director Saiyed Atiq Raza sold 29,544 shares of the company's stock in a transaction on Tuesday, July 29th. The shares were sold at an average price of $10.07, for a total value of $297,508.08. Following the completion of the transaction, the director owned 653,118 shares in the company, valued at approximately $6,576,898.26. This represents a 4.33% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CFO Nicholas B. Hawkins sold 11,000 shares of the company's stock in a transaction on Thursday, May 8th. The shares were sold at an average price of $7.54, for a total transaction of $82,940.00. Following the completion of the transaction, the chief financial officer owned 165,596 shares of the company's stock, valued at approximately $1,248,593.84. The trade was a 6.23% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 164,004 shares of company stock worth $1,543,564. Corporate insiders own 33.70% of the company's stock.

Institutional Trading of Arteris

An institutional investor recently bought a new position in Arteris stock. Strs Ohio purchased a new stake in Arteris, Inc. (NASDAQ:AIP - Free Report) in the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 15,100 shares of the company's stock, valued at approximately $104,000. Hedge funds and other institutional investors own 64.36% of the company's stock.

Arteris Company Profile

(Get Free Report)

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

Featured Stories

Earnings History for Arteris (NASDAQ:AIP)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Arteris Right Now?

Before you consider Arteris, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.

While Arteris currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Overlooked AI Stocks That Chipmakers Can’t Live Without
Palantir & AMD Earnings: Massive Options Setups Ahead
3 Value Plays Set to Explode

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines